CureMetrix develops AI algorithms that enhance the detection of breast cancer and heart disease through advanced imaging analysis. Their technology increases diagnostic accuracy, facilitating earlier intervention and improving patient outcomes in healthcare settings worldwide.
Funding
Funding not disclosed
Founders
Product
Problem
Radiologists face challenges in accurately and efficiently detecting breast cancer and heart disease through mammography and other imaging techniques. Traditional methods can lead to missed anomalies, false positives, and increased recall rates, causing unnecessary patient anxiety and healthcare costs. The increasing volume of mammograms further strains radiologists' ability to prioritize cases effectively.
Solution
CureMetrix provides AI-driven software solutions designed to enhance the accuracy, efficiency, and workflow of radiologists in detecting breast cancer and assessing heart health. Their suite of products leverages advanced image analysis and deep learning algorithms to identify suspicious anomalies, reduce false positives, and prioritize mammography worklists. By providing radiologists with data-driven insights and decision support tools, CureMetrix aims to improve clinical outcomes, reduce healthcare costs, and increase assurance for imaging centers, hospital systems, and patients. The company's technology supports earlier and more accurate detection of breast cancer, as well as the identification of potential heart issues through mammograms.
Target Audience
The primary target audience includes radiologists, radiology centers, healthcare systems, and hospitals seeking to improve the accuracy and efficiency of breast cancer and heart disease detection through advanced imaging analysis.
Features
- cmTriage: AI-based workflow optimization software that triages and prioritizes mammography worklists based on suspicious cases.
- cmAssist: AI-CAD system that assists radiologists in identifying and marking anomalies in breast cancer screening, potentially detecting cancers up to six years earlier.
- cmAngio: Software that analyzes mammograms to assess a woman's risk of heart disease by measuring breast arterial calcifications.
- cmAudit: Software designed to provide comprehensive audit trails and reporting for mammography procedures.
- AI-driven image analysis to reduce false positives and improve breast cancer detection rates.
- Algorithms designed to improve the evaluation of dense breast tissue.
- Potential to track treatment response over time by identifying and classifying suspicious anomalies.
- FDA-cleared solutions for mammography workflow optimization and breast cancer screening.